HARRIS ASSOCIATES L P
Position in CRL — Charles River Laboratories International, Inc.
CIK 813917
CHICAGO, IL
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$371,443,560
+$36,794,716 QoQ
Shares Held
2,153,296
+28.4% QoQ
Ownership
4.47%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HARRIS ASSOCIATES L P holds $3,017,293,763 across 6 Diagnostics & Research names. CRL ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
12,183,275 | $2,077,735,717 | |
| 2 | ICLR |
Icon PLC
|
4,351,317 | $481,516,739 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,153,296 | $371,443,560 | |
| 4 | WAT |
Waters Corp /De/
|
288,712 | $85,978,433 | |
| 5 | DHR |
Danaher Corp /De/
|
1,838 | $348,484 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
482 | $270,830 |
All Filings in CRL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $371,443,560 | 2,153,296 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $334,648,844 | 1,677,606 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $230,478,722 | 1,473,084 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $176,452,127 | 1,162,935 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||